Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The fungal plasma membrane H+-ATPase (primarily Pma1p) is an essential P-type ATPase responsible for maintaining the electrochemical gradient across the fungal cell membrane (Serrano, 1989; UniProt P05030). By pumping protons out of the cytoplasm, it establishes a membrane potential and a pH gradient that are vital for the secondary active transport of nutrients such as amino acids and sugars (Monk et al., 1995). Because this pump is critical for fungal growth and survival and lacks a direct human ortholog, it represents a highly attractive target for the development of novel antifungal agents (Perlin et al., 1997). Inhibition of Pma1p leads to rapid intracellular acidification and metabolic collapse, effectively killing the fungal cell (Chan et al., 2017). Current research focuses on identifying small molecules, such as ebselen and certain cinnamic acid derivatives, that selectively bind to the fungal pump over human ion-transporting ATPases to minimize side effects (Nakamura et al., 1997; Billack et al., 2001).
Inhibition of the P-type ATPase enzyme activity, preventing the extrusion of protons from the cytoplasm to the extracellular space. This leads to rapid intracellular acidification, dissipation of the membrane potential, and the subsequent cessation of secondary active transport of essential nutrients (Monk et al., 1995; Chan et al., 2017).
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Plasma membrane H+-ATPase (PMA1) (PMA1).